Feed Preview

Immunotherapy (Preprints)

Immunotherapy (Preprints)   diagram by undefined

Cancer immunotherapy is an important field of research that is looking at controlling cancer and tumor growth by activating the individuals own immune system. Recent studies have utilized chimeric antigen receptor t-cell therapy, immune checkpoint inhibitors and neoantigen vaccines. Discover the latest preprints on cancer immunotherapy here.

Top 20 most recent papers
bioRxiv

Plasma-derived exosomal analysis and deconvolution enables prediction and tracking of melanoma checkpoint blockade response

bioRxivOctober 18, 2019
Alvin H ShiGenevieve Marie Boland
6
bioRxiv

Evolutionary Origins of Recurrent Pancreatic Cancer

bioRxivOctober 31, 2019
Hitomi SakamotoChristine A. Iacobuzio-Donahue
38
bioRxiv

Temporal and spatial modulation of the immune response of the murine Gl261 glioma tumor microenvironment

bioRxivNovember 28, 2019
Kelly J McKelveyViive M Howell
9
bioRxiv

Effective Combination Immunotherapy using Oncolytic Viruses to Deliver CAR Targets to Solid Tumors

bioRxivNovember 16, 2019
Anthony K ParkSaul Jonathan Priceman
10
bioRxiv

Genome-wide profiling of druggable active tumor defense mechanisms to enhance cancer immunotherapy

bioRxivNovember 15, 2019
Rigel Joseph KishtonNicholas P. Restifo
32
1
bioRxiv

Lymph node follicle formation and vaccination responses reconstituted in vitro in a human Organ Chip

bioRxivOctober 16, 2019
Girija GoyalDonald E. Ingber
23
3
bioRxiv

Immunotherapy of CT26 murine tumors is characterized by an oligoclonal response against the AH1 tumor rejection antigen

bioRxivOctober 2, 2019
Philipp ProbstDario Neri
3
bioRxiv

Single cell multiomic analysis of T cell exhaustion in vitro

bioRxivNovember 17, 2019
Mirko CorselliPratip K Chattopadhyay
28
bioRxiv

Cell therapy as a new approach on hepatic fibrosis of murine model of Schistosoma mansoni infection

bioRxivNovember 25, 2019
Muslimah Alsulami
1
bioRxiv

Dietary carotenoid supplementation facilitates egg laying in a wild passerine

bioRxivOctober 4, 2019
Jorge García-CampaJudith Morales
5
3
bioRxiv

Validation of a high-performance liquid chromatography-tandem mass spectrometry immunopeptidomics assay for the identification of HLA class I ligands suitable for pharmaceutical therapies

bioRxivOctober 29, 2019
Michael GhoshStefan Stevanovic
4
bioRxiv

Recurrent Neoantigens in Colorectal Cancer as Potential Immunotherapy Targets

bioRxivNovember 13, 2019
Chao ChenBo Li
6
bioRxiv

The immunocytokine L19-TNF eradicates Sarcomas in combination with Chemotherapy or with immune check-point inhibitors

bioRxivNovember 11, 2019
Riccardo CorbellariRoberto De Luca
3
bioRxiv

Cryopreservation impairs cytotoxicity and migration of NK cells in 3-D tissue: Implications for cancer immunotherapy

bioRxivOctober 21, 2019
Christoph MarkCaroline J. Voskens
22
bioRxiv

Prediction of breast cancer proteins using molecular descriptors and artificial neural networks: a focus on cancer immunotherapy proteins, metastasis driver proteins, and RNA-binding proteins

bioRxivNovember 13, 2019
Andrés López-CortésCristian-Robert Munteanu
28
bioRxiv

The immunogenic potential of recurrent cancer drug resistance mutations: an in silico study

bioRxivNovember 17, 2019
Marco PuntaStefano Lise
8
bioRxiv

Branched evolution and genomic intratumor heterogeneity in the pathogenesis of cutaneous T-cell lymphoma

bioRxivOctober 15, 2019
Aishwarya IyerRobert Gniadecki
11
1
bioRxiv

Feasibility of real-time in vivo 89Zr-DFO-labeled CAR T-cell trafficking using PET imaging

bioRxivOctober 1, 2019
Suk Hyun LeeJin-Sook Ryu
4
bioRxiv

USMPep: Universal Sequence Models for Major Histocompatibility Complex Binding Affinity Prediction

bioRxivOctober 24, 2019
Johanna VielhabenNils Strodthoff
6
bioRxiv

Lipid-mediated insertion of Toll-like receptor (TLR) ligands for facile immune cell engineering

bioRxivNovember 16, 2019
Michael H. ZhangGregory Lee Szeto
21

See more papers from this feed

Related Feeds

© 2019 Meta ULC. All rights reserved
/feed-previews/immunotherapy-preprints/ff266c47-e266-4966-9c1e-c7e480abb2f9